Given the investment horizon of 30 days, and your above average risk tolerance our recommendation regarding Strata Skin Sciences is 'Not Rated'. Macroaxis provides Strata Skin buy hold or sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding MELA positions. The advice algorithm takes into account all of Strata Skin Sciences available fundamental, technical, and predictive indicators you will find on this site. The advice is provided from MELA buy-and-hold prospective. Please see also Stocks Correlation.
Recommendations are not available for this entity. Please try other suggestion below
We are unable to locate Strata Skin Sciences Advice at this time.
If you believe the indicator you are trying to look up is valid please let us know and we will check it out.
Strata Skin Sciences is not yet fully synchronised with the market data
Strata Skin Sciences has some characteristics of a very speculative penny stock
Strata Skin Sciences has high likelihood to experience some financial distress in the next 2 years
The company currently holds 20.26M in liabilities with Debt to Equity (D/E) ratio of 1.28 which is about average as compared to similar companies. Strata Skin Sciences has Current Ratio of 0.76 indicating that it has a negative working capital and may not be able to pay financial obligations when they are due.
The entity reported previous year revenue of 9.39M. Net Loss for the year was (33.71M) with loss before overhead, payroll, taxes, and interest of (4.02M).
ELECTRO-OPTICAL S currently holds about 3.17M in cash with (10.09M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.31.
Roughly 13.0% of Strata Skin outstanding shares are owned by corporate insiders